Bocxman, you've mentioned the need for independent validation to move the stock. How will this validation be presented? Is is possible that it could be presented at the ISOBM conference next week? Or will we see it elsewhere, say, in a medical journal or on Abbott's web site?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.